Press Releases
 
Passing of Dr Sydney Brenner, Nobel Laureate, Pioneer in Molecular Biology, A*Star Senior Fellow

SINGAPORE, 5 April 2019 -- (ACN Newswire) -- It is with deep regret that the Agency for Science, Technology and Research (A*STAR) announces the passing of Dr Sydney Brenner, Honorary Singapore Citizen, and A*STAR Senior Fellow, early this morning.

Dr Brenner was conferred the Nobel Prize in Physiology or Medicine in 2002 for his pioneering work in the field of molecular biology. For over six decades, he had shaped modern biology and understanding of the genetic code.

His dedication and commitment to Singapore over the past three and a half decades have also left an indelible mark on our nation's R&D journey. Dr Brenner challenged all of us to think ahead for the future, and spurred the establishment of Singapore's first major research institute for science, the Institute of Molecular and Cell Biology (IMCB), in 1985. This was a crucial stepping stone for Singapore's push into the biomedical sciences. Through his support, the A*STAR Graduate Academy was established to help Singapore build its own pipeline of young scientists and engineers.

"A giant in the field of molecular biology, Sydney played a key role in shaping Singapore's research and development landscape from its early years. His deep contributions in biomedical sciences have helped put Singapore on the global map. Today, Singapore is an emerging biomedical hub. Sydney will be remembered by the scientific community and beyond. My thoughts and prayers are with his family." - Ms Chan Lai Fung, Chairman, A*STAR

"Dr Brenner's contributions have shaped Singapore's R&D journey, from biomedical research to talent development. He has been an inspiration to those he has worked closely with over the years, as well as those who have admired him from afar. No doubt, he will continue to be a source of inspiration for generations of scientists to come. Our thoughts are with Dr Brenner's family." - Mr Frederick Chew, Chief Executive Officer, A*STAR

More information on Dr Brenner's achievements can be found in Annex A.

ANNEX A: Dr Sydney Brenner's Achievements

Dr Sydney Brenner was a renowned pioneer in molecular biology. His many achievements included deciphering how the triplet codon works, the discovery of messenger RNA, and the use of the worm, C. elegans, as a model system for human disease. This culminated in his being conferred the Nobel Prize in Physiology or Medicine in 2002.

Dr Brenner's dedication and commitment to Singapore has also contributed to policies and initiatives that have left an indelible mark on the nation's R&D journey. Since his first visit in 1983, he had played a key role in building the biomedical sciences in Singapore. Dr Brenner challenged the nation to think ahead for the future, which led to the establishment of Singapore's first major research institute for science, the Institute of Molecular and Cell Biology or IMCB, in 1985. This proved to be a turning point and crucial stepping stone for the country's foray into the biomedical sciences.

Over the past three and a half decades, Dr Brenner guided Singapore on its R&D journey, including his recent capacity as the Scientific Advisor to former Chairman A*STAR Lim Chuan Poh. For his contributions, Dr Brenner received many accolades, including the Distinguished Friends of Singapore in 2000, Honorary Citizen in 2003 and the National Science and Technology Medal in 2006.

Dr Brenner had a strong passion in ensuring that young people receive a good education in Science. Through his support, the A*STAR Graduate Academy was established to help Singapore build its own pipeline of young scientists and engineers, many of whom now contribute in our research institutes, universities, polytechnics, hospitals and local companies. This has helped raise the standing and reputation of Singapore as one of the leading global centres for science, research and education.

Last November, a book entitled "10-on-10: The Chronicles of Evolution" was launched as tribute to Dr Brenner's extraordinary vision and legacy. The book was written by 24 renowned scientists and is a compilation of a series of lectures on evolution, that was the brainchild of Dr Brenner.

Photos of Sydney Brenner.zip (16.1 MB) https://bit.ly/2YRuM1K

About the Agency for Science, Technology and Research (A*STAR)

The Agency for Science, Technology and Research (A*STAR) is Singapore's lead public sector agency that spearheads economic oriented research to advance scientific discovery and develop innovative technology. Through open innovation, it collaborates with its partners in both the public and private sectors to benefit society.

A*STAR's R&D activities span biomedical sciences and physical sciences and engineering, with research entities primarily located in Biopolis and Fusionopolis. For ongoing news, please visit http://www.a-star.edu.sg.

For further media queries, please contact:
Ms Gladys Chung
A*STAR Corporate Communications
Email:
Tel/Mobile: +65 6826 6348 / +65 9680 2284

Mr Robin Chan
A*STAR Corporate Communications
Email:
Tel/Mobile: +65 6517 7940 / +65 9759 2284

# # #


Submitted by ACN Newswire, ACN Newswire on Friday, 5 April 2019 at 7:41 PM
Category: Science & Research
 
Related News

Asia Pacific Organic Personal Care Ingredients Market Report-2024
Thursday, 18 Apr 2019

Asia Pacific Nasal Drops Market: Status and Forecast 2024
Wednesday, 17 Apr 2019

Quantum dot imaging advances
Tuesday, 16 Apr 2019

Global Arthroscopy Devices Market: Status and Forecast 2025
Tuesday, 16 Apr 2019

Global Cardiac Assist Devices Market: Status and Forecast 2025
Monday, 15 Apr 2019

Related Events

Aerospace Mental Health and Wellbeing Conference RAeS London - 22/23 May 2019
Wednesday, 22 May 2019

20th International Union for Quaternary Research Congress (INQUA 2019)
Thursday, 25 Jul 2019

Latest News

HKTDC Hong Kong Houseware Fair and Home Textiles Fair open today
Saturday, 20 Apr 2019

Dooley KP Is Set To Release The Song Ignant With Kountrysyde Records On 15th April 2019
Saturday, 20 Apr 2019

Local Platform for Services and Products, theconnectguam.com, Launches New App. Search Made Easy
Saturday, 20 Apr 2019

Understand how Acrylic Rendering Can Benefit You and your House
Saturday, 20 Apr 2019

Understand how Acrylic Rendering Can Benefit You as well as your House
Saturday, 20 Apr 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Saturday, 20 April 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Palo Alto Networks: Palo Alto Networks Next Generation Firewall Hands-on Seminar
  • DOZ Live Inspirational Conference (DOZ Live)
  • 3rd Annual NASH Summit | April 22-25, 2019 | Boston, MA
  • Rx Drug Abuse and Heroin Summit
  • European NeoAg Summit 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.